Quick Answer
iBio, Inc. reported Cash And Cash Equivalents At Carrying Value of $8.58 million for the year ending 2025.
- iBio, Inc. showed a decrease of -39.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from iBio, Inc.'s annual report (Form 10-K), filed with the SEC on September 5, 2025.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2011 to 2025), iBio, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 201.9%.
- Historical annual values: Fiscal year 2025: $8.58 million | Fiscal year 2024: $14.21 million | Fiscal year 2023: $4.30 million | Fiscal year 2022: $22.68 million | Fiscal year 2021: $77.40 million | Fiscal year 2020: $55.11 million | Fiscal year 2019: $4.42 million | Fiscal year 2018: $4.42 million | Fiscal year 2017: $15.93 million | Fiscal year 2016: $15.93 million | Fiscal year 2015: $9.49 million | Fiscal year 2014: $3.59 million | Fiscal year 2013: $4.41 million | Fiscal year 2012: $5.62 million | Fiscal year 2011: $2.84 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: